Mainz Biomed B.V. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.27 | -$0.16 | -$0.22 |
| Q2 2024 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q3 2024 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q1 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
Mainz Biomed B.V. Earnings Date And Information
Mainz Biomed B.V. last posted its earnings results on Tuesday, April 9th, 2024. The company reported $-0.24 earnings per share for the quarter, topping analysts' consensus estimates of $-0.32 by $0.08. The company had revenue of 214,761 for the quarter and had revenue of 895,479 for the year. Mainz Biomed B.V. has generated $-2 earnings per share over the last year ($-1.62 diluted earnings per share) and currently has a price-to-earnings ratio of -0.24. Mainz Biomed B.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 21st, 2024 based on prior year's report dates.
Mainz Biomed B.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/08/2024 | Q4 2023 | -$0.32 | -$0.24 | 0.08 | $253,332 | $214,761 |
| 09/29/2023 | Q3 2023 | -$0.39 | $333,333 | $181,669 | ||
| 06/30/2023 | Q2 2023 | -$0.55 | $283,333 | $248,945 | ||
| 03/31/2023 | Q1 2023 | -$0.45 | $266,667 | $250,104 | ||
| 04/07/2023 | Q4 2022 | -$0.58 | $278,500 | $193,281 | ||
| 09/29/2022 | Q3 2022 | -$0.39 | $96,791 | |||
| 06/29/2022 | Q2 2022 | -$0.50 | $139,240 | |||
| 03/30/2022 | Q1 2022 | -$0.42 | $100,565 | |||
| 05/02/2022 | Q4 2021 | -$1.30 | $160,037 | |||
| 09/29/2021 | Q3 2021 | -$0.41 | $144,337 | |||
| 06/29/2021 | Q2 2021 | -$0.02 | $417,311 | |||
| 03/30/2021 | Q1 2021 | -$0.00 | $144,337 | |||
| 12/30/2020 | Q4 2020 | -$0.01 | $123,391 | |||
| 09/29/2020 | Q3 2020 | -$0.01 | $123,391 | |||
| 06/29/2020 | Q2 2020 | -$0.01 | $123,391 | |||
| 03/30/2020 | Q1 2020 | -$0.01 | $123,391 | |||
| 12/30/2019 | Q4 2019 | -$0.02 | $70,348 | |||
| 09/29/2019 | Q3 2019 | -$0.02 | $70,348 | |||
| 06/29/2019 | Q2 2019 | -$0.02 | $70,348 | |||
| 03/30/2019 | Q1 2019 | -$0.02 | $70,348 |
Mainz Biomed B.V. Earnings: Frequently Asked Questions
-
When is Mainz Biomed B.V.'s earnings date?
Mainz Biomed B.V. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 21st, 2024 based off last year's report dates.
-
Did Mainz Biomed B.V. beat their earnings estimates last quarter?
In the previous quarter, Mainz Biomed B.V. (:MYNZ) reported $-0.24 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.32 by $0.08.
-
How can I listen to Mainz Biomed B.V.'s earnings conference call?
The conference call for Mainz Biomed B.V.'s latest earnings report can be listened to online.
-
How can I read Mainz Biomed B.V.'s conference call transcript?
The conference call transcript for Mainz Biomed B.V.'s latest earnings report can be read online.
-
How much revenue does Mainz Biomed B.V. generate each year?
Mainz Biomed B.V. (:MYNZ) has a recorded annual revenue of $895,479.
-
How much profit does Mainz Biomed B.V. generate each year?
Mainz Biomed B.V. (:MYNZ) has a recorded net income of $895,479. Mainz Biomed B.V. has generated $-1.62 earnings per share over the last four quarters.
-
What is Mainz Biomed B.V.'s price-to-earnings ratio?
Mainz Biomed B.V. (:MYNZ) has a price-to-earnings ratio of -0.24 and price/earnings-to-growth ratio is -0.01.
